Aim: We used mixture cure mode to separately investigate the risk factors for long-term and short-term survival of colorectal cancer patients.
Background: Colorectal cancer (CRC) is the second most common cancer worldwide. In cancer studies, patients’ survival is the most important indicator of patients’ status. Classical methods in analyzing the survival data usually apply Cox proportional hazard regression.
Methods: The study was performed on 1121 patients diagnosed with colorectal cancer. Mixture cure model with Weibull distribution and logit link function was fitted to data.
Results: Odds of long-term survival for rectum cancer patients were lower than for colon cancer patients (OR=0.29(0.09, 0.9)). Also, patients with the advanced stage of the disease had lower odds of long-term survival compared to early-stage patients (OR=0.24(0.06, 0.86)).
In the short-term, the hazard of death for people with normal BMI was lower than the underweight group (HR=0.4(0.21, 0.76)). The short-term hazard of death for rectum cancer was about half of the short-term hazard for colon cancer (HR=0.49(0.29, 0.81)). Further, people with moderately (HR=2.11(1.26, 3.55)) and poorly (HR=4.04(2.03, 8.03)) differentiated tumor grade had a higher short-term hazard of death compared to people with well-differentiated grade.
Conclusion: Predictive variables of colorectal cancer survival showed different effects in short- and long -terms. Site topography was a prognosis for both long-term and short-term survival; BMI and tumor grade were short-term predictors of survival while stage was a long-term predictor of survival.
Keywords: Mixture cure model, Colorectal cancer, Survival.
(Please cite as: Amanpour F, Akbari S, Azizmohammad Looha M, Abdehagh M, Pourhoseingholi MA. Mixture cure model for estimating short-term and long-term colorectal cancer survival. Gastroenterol Hepatol Bed Bench 2019;12(Suppl.1):S37-S43).
Cancer Today. Website. Available from: https://gco.iarc.fr/today/ [Accessed Oct 15, 2019 ]
Pourhoseingholi MA, Vahedi M, Moghimi-Dehkordi B, Pourhoseingholi A, Ghafarnejad F, Maserat E, et al. Burden of hospitalization for gastrointestinal tract cancer patients-Results from a cross-sectional study in Tehran. Asian Pac J Cancer Prev 2009;10:107-10.
Azadeh S, Moghimi-Dehkordi B, Fatem SR, Pourhoseingholi MA, Ghiasi S, Zali MR. Colorectal cancer in Iran: an epidemiological study. Asian Pac J Cancer Prev 2008;9:123-6.
Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116:544-73.
Fu J, Yang J, Tan Y, Jiang M, Wen F, Huang Y, et al. Young patients (= 35 years old) with colorectal cancer have worse outcomes due to more advanced disease: a 30-year retrospective review. Medicine 2014;93:e135.
Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 2009;22:191-7.
Mohammadzadeh M, Seyednejhad F, Naghavi-Behzad M, Ahmadi-Dashatan R, Alikhah H, Shayan-Karkon F, et al. Risk Factors of Colorectal Cancer in Northwest Iran. J Clin Res Governance 2014;3:158-61.
Moghimi Dehkordi B, Safaei A, Pourhosseingholi MA, Vahedi M, Habibi M, Pourhosseingholi A, et al. Prevalence of positive family history of colorectal cancer in the Iranian general population Iran. J Cancer Prev 2010;3:28-31.
Kleinbaum DG, Klein M. Survival Analysis: Third Edition. Springer, 2012.
Klein JP, Houwelingen HC, Ibrahim JG, Scheike TH. Handbook of Survival Analysis. Chapman and Hall /CRC Press, 2014.
Othus M, Barlogie B, Leblanc ML, Crowley JJ. Cure models as a useful statistical tool for analyzing survival. Clin Cancer Res 2012;18:3731-6.
Azizmohammad Looha M, Pourhoseingholi MA, Nasserinejad M, Najafimehr H, Zali MR. Application of a non-parametric non-mixture cure rate model for analyzing the survival of patients with colorectal cancer in Iran. Epidemiol Health 2018;40:e2018045.
van Eeghen EE, Bakker SD, van Bochove A, Loffeld RJ. Impact of age and comorbidity on survival in colorectal cancer. J Gastrointest Oncol 2015;6:605-12.
Baghestani AR, Daneshva T, Pourhoseingholi MA, Asadzadeh H. Survival of Colorectal Cancer in the Presence of Competing- Risks - Modeling by Weibull Distribution. Asian Pac J Cancer Prev 2016;17:1193-6.
Morrison DS, Parr CL, Lam TH, Ueshima H, Kim HC, Jee SH, et al. Behavioural and metabolic risk factors for mortality from colon and rectum cancer: analysis of data from the Asia-Pacific Cohort Studies Collaboration. Asian Pac J Cancer Prev 2013;14:1083-7.
Rasouli MA, Moradi G, Roshani D, Nikkhoo B, Ghaderi E, Ghaytasi B. Prognostic factors and survival of colorectal cancer in Kurdistan province, Iran: A population-based study (2009-2014). Medicine 2017;96:e5941.
Golfam F, Golfam P, Neghabi Z. Frequency of all types of colorectal tumors in the patients referred to selected hospitals in tehran. Iran Red Crescent Med J 2013;15:473-6.
Arnold M, Charvat H, Freisling H, Noh H, Adami H-O, Soerjomataram I, et al. Adult overweight and survival from breast and colorectal cancer in Swedish women. Cancer Epidemiol Biomarkers Prev 2019;28:1518-24.
Maringe C, Walters S, Rachet B, Butler J, Fields T, Finan P, et al. Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007. Acta Oncologica 2013;52:919-32.
Abdelsattar ZM, Wong SL, Regenbogen SE, Jomaa DM, Hardiman KM, Hendren S. Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening. Cancer 2016;122:929-34.
Baghestani AR, Gohari MR, Orooji A, Pourhoseingholi MA, Zali MR. Evaluation of parametric models by the prediction error in colorectal cancer survival analysis. Gastroenterol Hepatol Bed Bench 2015;8:183-7.
Majek O, Gondos A, Jansen L, Emrich K, Holleczek B, Katalinic A, et al. Sex differences in colorectal cancer survival: population-based analysis of 164,996 colorectal cancer patients in Germany. PloS one 2013;8:e68077.
Micheli A, Ciampichini R, Oberaigner W, Ciccolallo L, de Vries E, Izarzugaza I, et al. The advantage of women in cancer survival: an analysis of EUROCARE-4 data. Eur J Cancer 2009;45:1017-27.
Yang Y, Wang G, He J, Ren S, Wu F, Zhang J, et al. Gender differences in colorectal cancer survival: A meta-analysis. Int J Cancer 2017;141:1942-9.
Hines RB, Shanmugam C, Waterbor JW, McGwin G, Funkhouser E, Coffey CS, et al. Effect of Comorbidity and Body Mass Index on Colon Cancer Survival of African American and Caucasian Patients. Cancer 2009;115:5798-806.
Guraya SY. Association of type 2 diabetes mellitus and the risk of colorectal cancer: A meta-analysis and systematic review. World J Gastroenterol 2015;21:6026-31.
Zanders MM, Vissers PA, Haak HR, van de Poll-Franse LV. Colorectal cancer, diabetes and survival: epidemiological insights. Diabetes Metab 2014;40:120-7.
Ahmadi A, Mobasheri M, Hashemi-Nazari SS, Baradaran A, Choobini ZM. Prevalence of hypertension and type 2 diabetes mellitus in patients with colorectal cancer and their median survival time: A cohort study. J Res Med Sci 2014;19:850-4.
Saha S, Shaik M, Johnston G, Saha SK, Berbiglia L, Hicks M, et al. Tumor size predicts long-term survival in colon cancer: an analysis of the National Cancer Data Base. Am J Surg 2015;209:570-4.
Kirchhoff AC, Newcomb PA, Trentham-Dietz A, Nichols HB, Hampton JM. Family history and colorectal cancer survival in women. Fam Cancer 2008;7:287-92.
Bass AJ, Meyerhardt JA, Chan JA, Giovannucci EL, Fuchs CS. Family history and survival after colorectal cancer diagnosis. Cancer 2008;112:1222-9.